ProShares Ultra Bloomberg Natural Gas

United States Natural Gas

MicroSectors Gold Miners 3X Leveraged ETN

Direxion Daily TSLA Bull 1.5X Shares

Direxion Daily Gold Miners Bull 3X ETF

ProShares Ultra Silver

GraniteShares 1.25x Long Tesla Daily ETF

Altimmune Inc. Common Stock

Direxion Daily FTSE China Bull 3X ETF

Global X Silver Miners ETF

ProShares UltraShort Bloomberg Natrl Gas

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

T-REX 2X Inverse Tesla Daily Target ETF

Direxion Daily Gold Miners Bear 3X ETF

ProShares UltraShort Silver

Direxion Daily S&P Biotech Bear 3X ETF

Volatility Shares Trust 2x Ether ETF

VS TR 2x Long VIX Futures ETF

GraniteShares 2x Long AMZN Daily ETF

Direxion Daily 20+ Yr Trsy Bull 3X ETF

BloomZ Inc. Ordinary Shares

Neuraxis Inc. Common Stock

Siyata Mobile Inc. Common Shares

TNL Mediagene Ordinary Shares

Edible Garden AG Incorporated Common Stock

Eyenovia Inc. Common Stock

D-Wave Quantum Inc. Common Shares

Click Holdings Limited Ordinary Share

Mind Medicine (MindMed) Inc. Common Shares

Pony AI Inc. American Depositary Shares

Protagenic Therapeutics Inc. Common Stock

NWTN Inc. Class B Ordinary Shares

ASP Isotopes Inc. Common Stock

MicroAlgo Inc. Ordinary Shares

Twin Vee PowerCats Co. Common Stock

Eagle Materials Inc Common Stock

Canaan Inc. American Depositary Shares

Hyperscale Data Inc. Common Stock

Classover Holdings Inc. Class B Common Stock

New Fortress Energy Inc. Class A Common Stock

Click here to get full coverage on $MNMD stock is up 8% today. Here's what we see in our data. - Nasdaq

$MNMD stock is up 8% today. Here's what we see in our data.  Nasdaq

$MNMD stock is up 8% today. Here's what we see in our data. - Nasdaq

Click here to get full coverage on Mind Medicine (MNMD) Stocks Climb Amid FDA Focus on Psychedelics - GuruFocus

Mind Medicine (MNMD) Stocks Climb Amid FDA Focus on Psychedelics  GuruFocus

Mind Medicine (MNMD) Stocks Climb Amid FDA Focus on Psychedelics - GuruFocus

Click here to get full coverage on Was Jim Cramer Right About Mind Medicine (MNMD) Stock? - Yahoo Finance

Was Jim Cramer Right About Mind Medicine (MNMD) Stock?  Yahoo Finance

Was Jim Cramer Right About Mind Medicine (MNMD) Stock? - Yahoo Finance

Click here to get full coverage on Great week for Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) institutional investors after losing 28% over the previous year - simplywall.st

Great week for Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) institutional investors after losing 28% over the previous year  simplywall.st

Great week for Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) institutional investors after losing 28% over the previous year - simplywall.st

Click here to get full coverage on MindMed Announces New Employee Inducement Grants - Business Wire

MindMed Announces New Employee Inducement Grants  Business Wire

MindMed Announces New Employee Inducement Grants - Business Wire

Click here to get full coverage on (MNMD) Technical Data - news.stocktradersdaily.com

(MNMD) Technical Data  news.stocktradersdaily.com

(MNMD) Technical Data - news.stocktradersdaily.com

Click here to get full coverage on Does Mind Medicine MindMed (MNMD) Have the Potential to Rally 279.84% as Wall Street Analysts Expect? - MSN

Does Mind Medicine MindMed (MNMD) Have the Potential to Rally 279.84% as Wall Street Analysts Expect?  MSN

Does Mind Medicine MindMed (MNMD) Have the Potential to Rally 279.84% as Wall Street Analysts Expect? - MSN

Click here to get full coverage on MindMed Taps Former Jazz Pharma Executive to Lead MM120 Anxiety Drug Launch - Stock Titan

MindMed Taps Former Jazz Pharma Executive to Lead MM120 Anxiety Drug Launch  Stock Titan

MindMed Taps Former Jazz Pharma Executive to Lead MM120 Anxiety Drug Launch - Stock Titan

Click here to get full coverage on Mind Medicine: Initiating Hold Rating Due To Regulatory Challenges (NASDAQ:MNMD) - Seeking Alpha

Mind Medicine: Initiating Hold Rating Due To Regulatory Challenges (NASDAQ:MNMD)  Seeking Alpha

Mind Medicine: Initiating Hold Rating Due To Regulatory Challenges (NASDAQ:MNMD) - Seeking Alpha

Click here to get full coverage on MindMed Announces New Employee Inducement Grants | MNMD Stock News - GuruFocus

MindMed Announces New Employee Inducement Grants | MNMD Stock News  GuruFocus

MindMed Announces New Employee Inducement Grants | MNMD Stock News - GuruFocus

Click here to get full coverage on Mind Medicine: Strong Data, But Psychedelic Stigma Still Clouds Investor Confidence - Seeking Alpha

Mind Medicine: Strong Data, But Psychedelic Stigma Still Clouds Investor Confidence  Seeking Alpha

Mind Medicine: Strong Data, But Psychedelic Stigma Still Clouds Investor Confidence - Seeking Alpha

Click here to get full coverage on Institutional investors own a significant stake of 50% in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Yahoo Finance

Institutional investors own a significant stake of 50% in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)  Yahoo Finance

Institutional investors own a significant stake of 50% in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Yahoo Finance

Click here to get full coverage on MindMed to Report First Quarter 2025 Financial Results on May 8, 2025 - Business Wire

MindMed to Report First Quarter 2025 Financial Results on May 8, 2025  Business Wire

MindMed to Report First Quarter 2025 Financial Results on May 8, 2025 - Business Wire

Click here to get full coverage on MIND MEDICINE Earnings Results: $MNMD Reports Quarterly Earnings - Nasdaq

MIND MEDICINE Earnings Results: $MNMD Reports Quarterly Earnings  Nasdaq

MIND MEDICINE Earnings Results: $MNMD Reports Quarterly Earnings - Nasdaq

Click here to get full coverage on MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates - Business Wire

MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates  Business Wire

MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates - Business Wire

Click here to get full coverage on Is Mind Medicine (MNMD) the Best Multibagger Stock to Buy Heading into 2025? - Yahoo Finance

Is Mind Medicine (MNMD) the Best Multibagger Stock to Buy Heading into 2025?  Yahoo Finance

Is Mind Medicine (MNMD) the Best Multibagger Stock to Buy Heading into 2025? - Yahoo Finance

Click here to get full coverage on Mind Medicine Inc (MNMD) Q1 2025 Earnings Call Highlights: Strategic Advances Amidst Financial ... - Yahoo Finance

Mind Medicine Inc (MNMD) Q1 2025 Earnings Call Highlights: Strategic Advances Amidst Financial ...  Yahoo Finance

Mind Medicine Inc (MNMD) Q1 2025 Earnings Call Highlights: Strategic Advances Amidst Financial ... - Yahoo Finance

Click here to get full coverage on Evercore ISI Group Initiates Coverage of Mind Medicine (MNMD) with Outperform Recommendation - Nasdaq

Evercore ISI Group Initiates Coverage of Mind Medicine (MNMD) with Outperform Recommendation  Nasdaq

Evercore ISI Group Initiates Coverage of Mind Medicine (MNMD) with Outperform Recommendation - Nasdaq

Click here to get full coverage on MindMed to Present at Leerink’s Global Healthcare Conference 2025 - Business Wire

MindMed to Present at Leerink’s Global Healthcare Conference 2025  Business Wire

MindMed to Present at Leerink’s Global Healthcare Conference 2025 - Business Wire

Click here to get full coverage on Mind Medicine’s (MNMD) Recent Achievements Boosting Stock - TipRanks

Mind Medicine’s (MNMD) Recent Achievements Boosting Stock  TipRanks

Mind Medicine’s (MNMD) Recent Achievements Boosting Stock - TipRanks

Click here to get full coverage on Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) market cap touched US$601m last week, benefiting both retail investors who own 41% as well as institutions - Yahoo Finance

Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) market cap touched US$601m last week, benefiting both retail investors who own 41% as well as institutions  Yahoo Finance

Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) market cap touched US$601m last week, benefiting both retail investors who own 41% as well as institutions - Yahoo Finance

Click here to get full coverage on MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire

MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference  Business Wire

MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire

Click here to get full coverage on (MNMD) Long Term Investment Analysis - news.stocktradersdaily.com

(MNMD) Long Term Investment Analysis  news.stocktradersdaily.com

(MNMD) Long Term Investment Analysis - news.stocktradersdaily.com

Click here to get full coverage on MNMD - Mind Medicine Latest Stock News & Market Updates - Stock Titan

MNMD - Mind Medicine Latest Stock News & Market Updates  Stock Titan

MNMD - Mind Medicine Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on $MNMD stock is up 13% today. Here's what we see in our data. - Nasdaq

$MNMD stock is up 13% today. Here's what we see in our data.  Nasdaq

$MNMD stock is up 13% today. Here's what we see in our data. - Nasdaq

Click here to get full coverage on Notable Friday Option Activity: MNMD, TFC, INTU - Nasdaq

Notable Friday Option Activity: MNMD, TFC, INTU  Nasdaq

Notable Friday Option Activity: MNMD, TFC, INTU - Nasdaq

Click here to get full coverage on MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 - Business Wire

MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025  Business Wire

MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 - Business Wire

Click here to get full coverage on MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder - Business Wire

MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder  Business Wire

MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder - Business Wire

Click here to get full coverage on MindMed to Be Added to the Nasdaq Biotechnology Index - Business Wire

MindMed to Be Added to the Nasdaq Biotechnology Index  Business Wire

MindMed to Be Added to the Nasdaq Biotechnology Index - Business Wire

Click here to get full coverage on Mind Medicine Inc (MNMD) Q3 2024 Earnings Call Highlights: Strong Cash Position and Clinical ... - Yahoo Finance

Mind Medicine Inc (MNMD) Q3 2024 Earnings Call Highlights: Strong Cash Position and Clinical ...  Yahoo Finance

Mind Medicine Inc (MNMD) Q3 2024 Earnings Call Highlights: Strong Cash Position and Clinical ... - Yahoo Finance

Click here to get full coverage on MNMD stock touches 52-week low at $5.03 amid market challenges - Investing.com

MNMD stock touches 52-week low at $5.03 amid market challenges  Investing.com

MNMD stock touches 52-week low at $5.03 amid market challenges - Investing.com

Click here to get full coverage on Long Term Trading Analysis for (MNMD) - news.stocktradersdaily.com

Long Term Trading Analysis for (MNMD)  news.stocktradersdaily.com

Long Term Trading Analysis for (MNMD) - news.stocktradersdaily.com

Click here to get full coverage on Mind Medicine (MindMed) Inc. Announces Pricing of Public Offering - Business Wire

Mind Medicine (MindMed) Inc. Announces Pricing of Public Offering  Business Wire

Mind Medicine (MindMed) Inc. Announces Pricing of Public Offering - Business Wire

Click here to get full coverage on Mind Medicine (MNMD) Rating and Price Target Maintained by Chard - GuruFocus

Mind Medicine (MNMD) Rating and Price Target Maintained by Chard  GuruFocus

Mind Medicine (MNMD) Rating and Price Target Maintained by Chard - GuruFocus

Click here to get full coverage on Mind Medicine (MindMed) Inc. (MNMD): Among the Best Psychedelic Stocks to Buy in 2025 - Insider Monkey

Mind Medicine (MindMed) Inc. (MNMD): Among the Best Psychedelic Stocks to Buy in 2025  Insider Monkey

Mind Medicine (MindMed) Inc. (MNMD): Among the Best Psychedelic Stocks to Buy in 2025 - Insider Monkey

Click here to get full coverage on (MNMD) Investment Analysis - news.stocktradersdaily.com

(MNMD) Investment Analysis  news.stocktradersdaily.com

(MNMD) Investment Analysis - news.stocktradersdaily.com

Click here to get full coverage on MindMed Reports Third Quarter 2024 Financial Results and Business Updates - Business Wire

MindMed Reports Third Quarter 2024 Financial Results and Business Updates  Business Wire

MindMed Reports Third Quarter 2024 Financial Results and Business Updates - Business Wire

Click here to get full coverage on (MNMD) Investment Report - news.stocktradersdaily.com

(MNMD) Investment Report  news.stocktradersdaily.com

(MNMD) Investment Report - news.stocktradersdaily.com

Click here to get full coverage on MindMed's LSD Anxiety Drug: Revisiting, Rethinking, But Maintaining My 'Hold' Call (MNMD) - Seeking Alpha

MindMed's LSD Anxiety Drug: Revisiting, Rethinking, But Maintaining My 'Hold' Call (MNMD)  Seeking Alpha

MindMed's LSD Anxiety Drug: Revisiting, Rethinking, But Maintaining My 'Hold' Call (MNMD) - Seeking Alpha

Click here to get full coverage on MindMed Stock Skyrockets 94% Year to Date: What's Driving It? - Nasdaq

MindMed Stock Skyrockets 94% Year to Date: What's Driving It?  Nasdaq

MindMed Stock Skyrockets 94% Year to Date: What's Driving It? - Nasdaq

Click here to get full coverage on Why Mind Medicine Stock Is Skyrocketing Today - Nasdaq

Why Mind Medicine Stock Is Skyrocketing Today  Nasdaq

Why Mind Medicine Stock Is Skyrocketing Today - Nasdaq

Click here to get full coverage on MindMed (MNMD) Advances Phase 3 Trials with Growing Enthusiasm | - GuruFocus

MindMed (MNMD) Advances Phase 3 Trials with Growing Enthusiasm |  GuruFocus

MindMed (MNMD) Advances Phase 3 Trials with Growing Enthusiasm | - GuruFocus

Click here to get full coverage on Small Cap Stocks: Mind Medicine (MNMD) Is a Psychedelic Biotechnology Bet - Nasdaq

Small Cap Stocks: Mind Medicine (MNMD) Is a Psychedelic Biotechnology Bet  Nasdaq

Small Cap Stocks: Mind Medicine (MNMD) Is a Psychedelic Biotechnology Bet - Nasdaq

Click here to get full coverage on Mind Medicine (MNMD) Stock Surges on RFK Jr.'s HHS Confirmation - GuruFocus

Mind Medicine (MNMD) Stock Surges on RFK Jr.'s HHS Confirmation  GuruFocus

Mind Medicine (MNMD) Stock Surges on RFK Jr.'s HHS Confirmation - GuruFocus

Click here to get full coverage on Mind Medicine Inc (MNMD) Q4 2024 Earnings Call Highlights: Strategic Advances and Financial Fortification - GuruFocus

Mind Medicine Inc (MNMD) Q4 2024 Earnings Call Highlights: Strategic Advances and Financial Fortification  GuruFocus

Mind Medicine Inc (MNMD) Q4 2024 Earnings Call Highlights: Strategic Advances and Financial Fortification - GuruFocus

Click here to get full coverage on MindMed (MNMD) Stock Surges on Psychedelic Mushroom Developments - GuruFocus

MindMed (MNMD) Stock Surges on Psychedelic Mushroom Developments  GuruFocus

MindMed (MNMD) Stock Surges on Psychedelic Mushroom Developments - GuruFocus

Click here to get full coverage on MindMed Reports Second Quarter 2024 Financial Results and Business Updates - Business Wire

MindMed Reports Second Quarter 2024 Financial Results and Business Updates  Business Wire

MindMed Reports Second Quarter 2024 Financial Results and Business Updates - Business Wire

Click here to get full coverage on MindMed to Present at the 2025 RBC Capital Markets Global Health - GuruFocus

MindMed to Present at the 2025 RBC Capital Markets Global Health  GuruFocus

MindMed to Present at the 2025 RBC Capital Markets Global Health - GuruFocus

Click here to get full coverage on Mind Medicine (MindMed) Inc. SEC 10-K Report - TradingView

Mind Medicine (MindMed) Inc. SEC 10-K Report  TradingView

Mind Medicine (MindMed) Inc. SEC 10-K Report - TradingView

Click here to get full coverage on MindMed to Announce Q1 2025 Financial Results - TipRanks

MindMed to Announce Q1 2025 Financial Results  TipRanks

MindMed to Announce Q1 2025 Financial Results - TipRanks

Click here to get full coverage on MindMed Begins Phase 3 Study of MM120 for Major Depressive Disorder - TipRanks

MindMed Begins Phase 3 Study of MM120 for Major Depressive Disorder  TipRanks

MindMed Begins Phase 3 Study of MM120 for Major Depressive Disorder - TipRanks

Click here to get full coverage on MindMed to Report First Quarter 2025 Financial Results on May 8, 2025 | MNMD Stock News - GuruFocus

MindMed to Report First Quarter 2025 Financial Results on May 8, 2025 | MNMD Stock News  GuruFocus

MindMed to Report First Quarter 2025 Financial Results on May 8, 2025 | MNMD Stock News - GuruFocus

Click here to get full coverage on How the (MNMD) price action is used to our Advantage - news.stocktradersdaily.com

How the (MNMD) price action is used to our Advantage  news.stocktradersdaily.com

How the (MNMD) price action is used to our Advantage - news.stocktradersdaily.com

Click here to get full coverage on MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT) - Business Wire

MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT)  Business Wire

Mind Medicine Inc (MNMD)

Price Chart

Key Statistics

Technicals

About MNMD

Latest News

$MNMD stock is up 8% today. Here's what we see in our data. - Nasdaq

Mind Medicine (MNMD) Stocks Climb Amid FDA Focus on Psychedelics - GuruFocus

Was Jim Cramer Right About Mind Medicine (MNMD) Stock? - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers